摘要
胰岛素受体底物(IRS)-2分子1995年由ARAKI等成功克隆。作为细胞质中的适配蛋白,IRS-2主要连接胰岛素受体和含SH2区蛋白,介导胰岛素(INS)、胰岛素样生长因子(IGF)-1等信号通道,调节细胞新陈代谢、生长和分化,是INS信号胞内传导的重要分子。人类IRS-2基因定位于13q8.6,有两个外显子和一个内含子,黄体酮可增强其转录,TZD(PPARγ激动剂)能快捷明显地增加其表达。IRS-2-/-动物具有2型糖尿病(T2DM)的全部特征,IRS-2基因突变可能参与人类T2DM的发生。
Insulin receptor substrate (IRS)-2 molecule was successfully cloned by Araki and others in 1995. As a linker protein in cytoplasm, IRS-2 is an important molecule of INS signal intraeellular conduction with main functions of to connect insulin receptor to the proteins with SH2 area, to communicate the signal conduction passages of insulin (INS) and insulin-like growth factor (IGF)-1 and to regulate cell metabolism, growth and differentiation. Human IRS-2 gene is located at 13q8.6 with two exons and an intron. Progesterone can increase its transcription. TZD (PRARγ agonist) can quickly and markedly enhance its expression. IRS-2^-/- animals bear all characteristics of type 2 diabetes meUitus (T2DM). IRS-2 gene mutation may participate in the occurrence of human T2DM.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2005年第15期2305-2307,共3页
China Journal of Modern Medicine
基金
辽宁省科技厅重点科技攻关基金资助项目(2001225001-16)
关键词
胰岛素受体底物-2
2型糖尿病
胰岛素抵抗
Insulin receptor substrate-2
Type 2 diabetes mellitus
Insulin resistance